Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$6.89
+3.07%
Mkt Cap $2.45B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+103.3%
Consensus $14.00 vs current $6.89
NASDAQ·Healthcare·Biotechnology
$6.89
+3.07%
Mkt Cap $2.45B
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
+103.3%
Consensus $14.00 vs current $6.89